Tag: 2021 National Synthetic Biology Roadmap
Synthetic biology advancements propose $30B opportunity for Australia
A collaborative effort between CSIRO and Main Sequence Ventures has unveiled Australia's strides in adhering to ten recommendations outlined in the National Synthetic Biology Roadmap, indicating significant progress towards a potentially lucrative industry.
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
